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Background 
Guidelines recommend ambulatory or home blood pressure monitoring to improve 
hypertension diagnosis and monitoring. Both these methods are ascribed the same 
threshold values, but whether they produce similar results has not been established 
in certain patient groups. 
Methods 
Adults with mild/moderate stroke or transient ischaemic attack (N=80) completed two 
sets of ambulatory and home blood pressure monitoring. Systolic and diastolic blood 
pressure values from contemporaneous measurements were compared and the 
limits of agreement assessed. Exploratory analyses for predictive factors of any 
difference were conducted. 
Results 
Daytime ambulatory blood pressure values were consistently lower than home 
values, the mean difference in systolic blood pressure for initial ambulatory vs first 
home monitoring was -6.6 ± 13.5mmHg (p=<0.001), and final ambulatory vs second 
home monitoring -7.1 ± 11.0mmHg (p=<0.001). Mean diastolic blood pressure 
differences were -2.1 ± 8.5mmHg (p=0.03) and -2.0 ± 7.2mmHg (p=0.02). Limits of 
agreement for systolic blood pressure were -33.0 to 19.9mmHg and -28.7 to 
14.5mmHg for the two comparisons, and for DBP were -18.8 to 14.5mmHg and -16.1 
to 12.2mmHg respectively. The individual mean change in systolic blood pressure 
difference was 11.0 ± 8.3mmHg across the two comparisons.No predictive factors 
for these differences were identified.  
Conclusions 
Daytime ambulatory systolic and diastolic blood pressure values were significantly 
lower than home monitored values at both time points. Differences between the two 
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methods were not reproducible for individuals. Using the same threshold value for 
both out-of-office measurement methods may not be appropriate in patients with 
cerebrovascular disease. 
 
Key Words 
Blood pressure, blood pressure measurement/monitoring, hypertension, stroke, 
cerebrovascular disease. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Hypertension is a major modifiable risk factor for both primary and secondary stroke 
prevention.1, 2 Diagnosing hypertension and monitoring treatment response relies on 
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being able to obtain an accurate and reproducible measurement of blood pressure 
(BP). Clinic BP measurement (CBPM) values taken manually by auscultation with a 
sphygmomanometer have been the traditional standardized method, yet they are 
limited by factors such as inadequate technique, observer bias, terminal digit 
preference, and blood pressure variability.3, 4 Whilst some of these limitations may be 
overcome by taking multiple clinic measurements over time, in patients with the 
white coat phenomenon or masked hypertension an accurate BP is unlikely to be 
obtained using CBPM alone.5 For these reasons, and because they better predict 
cardiovascular risk,6-8 current hypertension guidelines recommend the additional use 
of out-of-office measurements (either ambulatory BP monitoring (ABPM) or home BP 
monitoring (HBPM)) to support diagnosis and for monitoring BP control.9-12 Some 
authorities recommend ABPM as the “gold standard”,9, 13 but HBPM has become 
more popular as evidence indicating that its use can improve BP control has 
emerged.14 However, whether HBPM is effective in patients with cerebrovascular 
disease remains uncertain.15 
 
Clinic BP values are frequently at variance with out-of-office values and so using the 
same diagnostic and monitoring threshold value for all BP measurement methods is 
not necessarily appropriate. Comparisons of daytime ABPM and CBPM suggest that 
for a CBPM of 140/90mmHg the equivalent readings from daytime ABPM are on 
average 4/3mmHg lower.16 The threshold set by several guideline groups for the 
upper limit of “normal” for daytime ABPM values is <135/85mmHg.9, 11, 12 The same 
threshold value has been ascribed to HBPM though this has not been fully 
established,13 with recent studies suggesting the threshold should be lower.17, 18 
Furthermore, there are limited comparisons of ABPM with HBPM, despite ABPM 
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being considered the reference standard. Reports of their equivalence are 
inconsistent, have not investigated the reproducibility of any variation between the 
two methods, and have not assessed their equivalence in high-risk patient groups.19-
25  
 
TEST-BP was a randomized controlled trial of HBPM with or without guided self-
management of antihypertensive therapy in a population with cerebrovascular 
disease, with participants also undertaking daytime ABPM contemporaneously to 
HBPM. The aims of this study were to evaluate if there are differences between BP 
values measured using daytime ABPM and HBPM, assess their reproducibility, and 
explore factors that may relate to any differences. 
 
Methods 
The methodology used in TEST-BP has been previously reported.26 Ethical approval 
was obtained from the NRES Committee East of England – Norfolk (ref: 
11/EE/0147). The trial was registered with the ISRCTN trial database (ISRCTN 
86192648) where the trial protocol is publicly available. 
The methodology as relevant to this analysis is summarized here.Adults with a 
history of stroke (National Institute of Health Stroke Scale (NIHSS) <15) or TIA, 
between 72 hours and twelve weeks post-event and requiring treatment for 
hypertension (defined as being on antihypertensive medications prior to the recent 
cerebrovascular event or having post-event untreated BP ≥140/90mmHg from the 
mean of three clinic readings) were included. Patients in atrial fibrillation, with life 
expectancy less than six months or with established cognitive impairment were 
excluded. Participants provided written informed consent before being randomised in 
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a 1:1:1 ratio to treatment as usual, home monitoring only, or home monitoring with 
guided self-management of blood pressure. BP data from participants in both home 
monitoring groups have been used for this secondary analysis. 
 
All participants underwent CBPM at screening, ABPM at baseline and six months, 
and HBPM at six weeks, three and five months. HBPM data from the recordings at 
three months were not used in this study. Clinic BP was measured by the trial nurse 
using asemi-automated oscillometric BP monitor and appropriately sized cuff (Omron 
705IT, Omron Healthcare UK Ltd., Milton Keynes, UK), with the subject seated, after 
five minutes rest following British Hypertension Society (BHS) guidelines,27 taking 
the mean of three measurements. ABPM was measured with a Spacelabs 90207 
monitor (Spacelabs Healthcare Ltd. (UK), Hertford, UK) set to measure BP every 20 
minutes during the daytime and hourly overnight (2200-0700) following NICE 
guidelines.9 HBPM was performed following guideline recommendations with 
participants taking duplicate readings twice daily at home for seven consecutive 
days.9, 11 Morning measurements were taken prior to antihypertensive medication 
and all measurements were taken before meals. Readings from day one were 
discarded prior to analysis. The home monitoring only group used a validated BHS 
approved monitor with integrated memory and printer (Omron 705IT, Omron 
Healthcare UK Ltd., Milton Keynes, UK). The home monitoring and guided self-
management group used a validated BHS approved monitor (A&D UA-767PBT, A&D 
Instruments Ltd., Abingdon, UK) with a linked Bluetooth modem (iModem; 
Netmedical, Utrecht, Netherlands) that automatically transmitted readings to the trial 
team to allow for treatment decisions to be made in conjunction with the participant. 
Different monitors were used in order to incorporate telemonitoring of results into the 
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intervention for the home monitoring with guided self-management group. Medication 
adherence was assessed using the Hill-Bone compliance questionnaire at baseline 
and six months. Participants were excluded from this analysis if any daytime ABPM 
recording had <14 readings or if any home monitoring period provided <21 readings. 
Medications were checked at each study visit and those who had their 
antihypertensive medications altered between recordings for comparison, or in the 
two weeks prior to any BP measurement were also excluded from this analysis. 
 
Outcomes for this analysis were the comparison of mean systolic BP (SBP) and 
diastolic BP (DBP) from the baseline daytime ABPM readings with the first (six week) 
HBPM readings, the follow-up ABPM readings with the last (five month) HBPM 
readings, and the CBPM readings with both the baseline daytime ABPM and first 
HBPM readings. 
 
Statistical Analysis 
Data were analysed using SPSS version 23.0. A comparison of those included and 
excluded in the analysis was based on a two-sample Student’s t-test and a chi-
squared test. Mean SBP and DBP for each measurement method was calculated 
with the standard deviation (SD). Paired Student’s t-tests were used to compare the 
mean difference in SBP and DBP between the measurement methods stated above. 
BP differences were first analysed for each intervention group separately and then 
data from both groups was pooled when it was apparent that there were no 
significant differences between the separate analyses. Sensitivity and specificity of 
the diagnostic accuracy of HBPM was assessed against daytime ABPM (as the 
reference standard) using the kappa statistic with a diagnostic threshold for 
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hypertension by both methods of ≥135/85mmHg.9, 11, 12 For the comparisons 
between contemporaneous ABPM and HBPM readings the limits of agreement for 
both SBP and DBP were assessed using Bland and Altman’s method.28 Exploratory 
univariate analyses were undertaken to investigate possible relationships between 
individual variance in SBP and DBP difference from ABPM and HBPM with potential 
predictor variables. Analyses were initially descriptive, using scatter plots for 
continuous variables and box and whisker plots for categorical variables, with formal 
testing using Pearson’s correlation for continuous variables and independent 
samples t tests for categorical variables only where appropriate. The variables tested 
were age, sex, body mass index, baseline clinic BP, being on antihypertensive 
treatment, history of diabetes, diagnosis (TIA or stroke), baseline disability depicted 
by modified Rankin score (mRS), baseline cognition assessed using Montreal 
Cognitive Assessment score, and the number of measurements from daytime ABPM 
and HBPM. 
 
Results 
Ninety-nine subjects were randomised to one of the two intervention arms involving 
HBPM. 19 were excluded, eight due to insufficient HBPM measurements from one or 
both of the recording periods and 11 because they had their antihypertensive 
medications changed between the ABPM and HBPM recording periods, leaving 80 
participants for this analysis. Demographics of those included compared to those 
excluded showed no significant between-group differences (Table I). All participants 
were ambulant with a modified Rankin Score <2. 
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Mean SBP and DBP by CBPM were higher than both daytime ABPM and HBPM, 
with values from HBPM being higher than ABPM (Table II). The mean SBP and DBP 
from HBPM were higher than values from ABPM for both comparisons and the 
difference was consistent over time (Figure 1). BP differences were similar for both 
intervention groups and independent of the home monitor that was used 
(Supplementary table I, online supplement). Comparing the mean SBP and DBP 
from morning and evening HBPM recordings with daytime ABPM separately 
revealed greater differences with morning readings, but this did not significantly alter 
the findings (Supplementary table II, online supplement). Self-reported medication 
adherence was excellent throughout the trial (median Hill-Bone score 9.0 
(interquartile range 1.0) at both baseline and follow-up). 
 
The limits of agreement for SBP from ABPM vs. HBPM were -33.0 to 19.9mmHg for 
the first comparison and -28.7 to 14.5mmHg for the second comparison (Figure 2). 
Limits of agreement for DBP were -18.8 to 14.5mmHg and -16.1 to 12.2mmHg 
respectively.  Although the difference in mean SBP and DBP from ABPM and HBPM 
for the whole cohort was consistent over time, the difference in BP recorded by each 
method was not consistent for individuals. The mean change in the difference 
between daytime ABPM SBP and HBPM SBP was 11.0 ± 8.3mmHg (range 0.65 to 
43.3mmHg). For DBP the mean change was 6.5 ± 5.1mmHg (range 0.21 to 
19.8mmHg (Figure 3). 
 
Using daytime ABPM as the reference standard and a diagnostic threshold value for 
hypertension of ≥135/85mmHg for both methods, HBPM had a diagnostic sensitivity 
of 76.1% and specificity of 55.9% (k=0.36, p=0.004) when comparing the baseline 
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and first readings. At follow-up HBPM had a diagnostic sensitivity of 70.8% and 
specificity of 55.4% (k=0.22, p=0.03). From the baseline daytime ABPM recordings 
46/80 (57.5%, 95% CI 46.3-67.9%) participants were classified as having 
uncontrolled hypertension and from the follow-up daytime ABPM the rate was 24/80 
(30.0%, 95% CI 20.0-40.3%). For HBPM, 50/80 (62.5%, 95% CI 52.5-72.7%) were 
classified as uncontrolled hypertension on the first recording and 42/80 (52.5%, 95% 
CI 41.7-63.6%) on the second recording. For the first comparison 54/80 (67.5%, 95% 
CI 57.8-77.8%) participants were classified the same according to both daytime 
ABPM and HBPM (35 uncontrolled hypertension and 19 controlled hypertension). 
For the second comparison this proportion was 48/80 (60.0%, 95% CI 49.4-71.6% 
(17 uncontrolled hypertension and 31 controlled hypertension)).  
 
In the exploratory analyses for independent predictor variables for the differences 
between daytime ABPM and HBPM values the descriptive testing only suggested 
possible relationships with baseline clinic SBP and being on antihypertensive 
treatment, with all other variables unrelated (Supplementary figures 1 and 2, 
online supplement). However, further testing for the relationship with baseline clinic 
SBP revealed no significant correlation with the first comparison and only a weak 
correlation (r=-0.25, p=0.02) with the second comparison. Further testing of the 
relationship with being on antihypertensive treatment was not possible due to the 
small number of untreated participants (N=5). 
 
Discussion 
This work aimed to assess if important differences exist, that may affect clinical 
management of BP levels in stroke or TIA patients, between the commonest 
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methods of assessing out-of-office BP levels. We found that significant and 
prominent differences exist in BP values obtained from daytime ABPM compared to 
HBPM in this patient group. The mean differences in BP values were consistent 
between the two groups (who used different home monitors) and over the two 
measurement phases of the six month trial, however, the limits of agreement were 
wide-ranging and BP differences between the two measurement methods were not 
reproducible for individuals across the two measurement periods. This suggests that 
daytime ABPM and HBPM may not be interchangeable methods as BP values 
obtained using one method cannot be used to infer values from the other. 
Furthermore, the difference between the methods was large enough to potentially 
affect patient management, with a mismatch in hypertension control at a threshold 
value of ≥135/85mmHg in 26/80 (32.5%) of participants at baseline and 32/80 
(40.0%) at outcome. This indicates that there is the potential for discordant treatment 
decisions depending on which method is used to gauge treatment response. We 
were unable to demonstrate any predictive factors for the observed differences in BP 
between the two methodologies, with the significant correlation between baseline 
clinic SBP and SBP difference from the second comparison probably being a chance 
finding.  
 
ABPM and HBPM have both been assessed against CBPM,16, 29 however, fewer 
studies have directly compared the two out-of-office methods  using an HBPM 
protocol consistent with current guidelines. One randomised controlled trial of the 
therapeutic effect of HBPM in a primary care cohort of treated hypertensive 
adultsreported a difference between daytime ABPM and HBPM of -3.1/+0.7mmHg at 
the end of the trial, though this difference was not assessed further.30 Three cross-
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sectional studies in a mixture of treated and untreated hypertensive adults have 
shown differences ranging from -5 to -7mmHg for SBP and -1 to -4mmHg for DBP, 
with mean ABPM values lower than HBPM in each study, similar to our results.19-21 
The limits of agreement we found are also comparable to those reported 
elsewhere.31 In contrast, one cohort study in untreated hypertensive adults reported 
no difference between BP values from HBPM and daytime ABPM.23 This 
inconsistency may relate to the age of included participants as other studies have 
demonstrated that differences in BP values from out-of-office methods are not 
consistent across age groups, with daytime ABPM values being higher than HBPM 
values in children but lower or similar in adults over 60 years old.24, 25 The age of our 
cohort may therefore partly explain our findings and the narrow age range of 
participants may explain why age was not a predictive factor for the differences we 
found. Nevertheless, the findings potentially remain of relevance to managing stroke 
secondary prevention as many stroke patients experience their first cerebrovascular 
event at older ages. Importantly, none of these studies have performed repeated BP 
measures to investigate the reproducibility of any differences. Both ABPM and 
HBPM have been individually shown to be reproducible.32 However, they do not 
seem to provide the same BP information for individuals, with one study showing 
that, despite both methods diagnosing the same proportion of a cohort with masked 
hypertension, almost half of those diagnosed as masked hypertensive on daytime 
ABPM were not according to HBPM.33 
 
Using ABPM as the reference standard and with a diagnostic threshold value of 
≥135/85mmHg, HBPM has been reported to have a diagnostic sensitivity of 86% and 
specificity 62% which is similar to our findings.22 Despite this, daytime ABPM and 
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HBPM have been ascribed the same threshold values for hypertension diagnosis.9, 
11, 12 Furthermore, they are deemed equivalent for categorizing patients by stage of 
hypertension.12 This may not be the case as other studies have suggested that the 
difference between them may depend upon BP level.34, 35 This may relate to 
increased blood pressure variability, which has been shown to increase with BP 
level,36 and could have a greater influence on mean BP from HBPM compared to 
ABPM due to the different number of measurements. Other factors which may be 
relevant include age, gender, and being on antihypertensive treatment.19, 35 Our data 
also suggested that the latter may be a relevant factor, but we were unable to 
formally test this due to our small sample size. A possible explanation for the 
relevance of antihypertensive treatment status is that morning HBPM measurements 
are routinely taken before antihypertensive medications, therefore capturing BP at 
the trough of antihypertensive activity. Due to the larger number of measurements 
obtained with ABPM throughout the day the influence of these ‘trough values’ will be 
diluted, resulting in a lower daytime mean BP than that obtained with HBPM. 
However, whilst our data did show that morning HBPM mean BP was higher than in 
the evening, the difference was not large enough to support this explanation.  
 
This study is, to the best of our knowledge, the first to compare different out-of-office 
BP measurement methods and assess their limits of agreement in a population with 
cerebrovascular disease. Given the prevalence of stroke and the importance of BP 
management in secondary stroke prevention we believe the study is of importance.1, 
2, 37Its main strength is that we were able to compare ABPM and HBPM 
measurements at two different time-points in the same population of patients who 
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were treated but had not altered therapy between measurement timings, thereby 
investigating the consistency of any discrepancy and its reproducibility in individuals. 
 
Limitations that should be considered include that this was a post-hoc analysis of 
data from a randomised controlled trial. The population recruited all had 
cerebrovascular disease and the majority were elderly and on treatment for 
hypertension. Consequently, our findings may not be generalizable to a broader 
population. Secondly, due to the relatively small sample size our findings should be 
interpreted with caution. Thirdly, due to the design of the trial, the two intervention 
groups used different home monitors and this could account for some of the 
difference with daytime ABPM values that was found. However, both types of 
monitor have been validated. Furthermore, we have shown that any differences with 
daytime ABPM values were not significantly different between the two groups and 
therefore are not likely to have been significantly influenced by the equipment. 
Fourthly, the majority of our participants were on antihypertensive treatment 
throughout the trial, which may have influenced BP readings. However, other studies 
discussed have also included participants on treatment and we have shown that 
poor adherence is unlikely to have been a confounding factor in our cohort.16, 19, 20, 30 
Fifthly, the ABPM and HBPM measurements that we have compared were not 
precisely contemporaneous which may have introduced some natural variation. 
However, we excluded patients whose antihypertensive medications were changed 
in between measurements for comparison to try to ensure stability. Also, we have 
shown that the group variation between methods was consistent over time. Some 
other studies discussed have also compared measurements up to four weeks apart. 
Finally, there was a larger than expected difference between the BP values from 
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clinic measurement and out-of-office measurement in our group suggesting a 
marked white coat effect in some individuals. Home BP values, but not ABPM 
values, could also have been influenced by any anxiety around BP measurement 
thereby influencing our findings. However, the difference between clinic vs. ABPM 
and clinic vs. HBPM was consistent with the difference between ABPM vs. HBPM 
suggesting that any differences were not attributable to measurement differences 
from just one method. Furthermore, although we did not assess it in our cohort, there 
is evidence to show that patients with cerebrovascular disease do not experience 
additional anxiety due to HBPM and they can reliably measure their own BP at 
home.38, 39 
 
In this patient group with incident cerebrovascular events, we found significant 
differences between BP values obtained from ABPM and HBPM leading to 
inconsistency in hypertension control status if the current guideline threshold of 
≥135/85mmHg is applied to both methods. This is clinically important because it 
creates the potential to over-treat individuals if relying on HBPM to assess treatment 
response, or conversely under-treat if relying on ABPM. The variation between 
methods is not consistent between individuals suggesting that ABPM and HBPM 
should not be considered interchangeable methods of BP evaluation. Considering 
this, the threshold value for monitoring BP treatment with HBPM may not be the 
same as that for initial diagnosis and at present may need to be individualised. 
Further work in larger cohorts of both treated and untreated hypertensive individuals 
to establish values for HBPM with ABPM as the reference standard would be 
valuable. 
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Table I: Baseline demographics of those included and excluded from analysis. Data 
presented are mean (SD) or frequency (%). Modified Rankin score is presented as 
median (interquartile range). No significant differences between groups.  
 Included (N=80) Excluded (N=19) 
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Age 74.1 (10.3) 75.4 (8.8) 
Male 53 (66%) 12 (63%) 
Diagnosis of TIA* 53 (66%) 14 (74%) 
Time from event to 
recruitment (weeks) 
8.9 (3.5) 9.1 (3.3) 
Baseline mRS† (stroke 
only) 
1.0 (1.0) 1.0 (1.0) 
BMI 28.6 (5.3) 26.8 (2.1) 
Never smoked 36 (45%) 6 (32%) 
Alcohol (units/week) 9.4 (12.0) 7.1 (8.3) 
On antihypertensive 
therapy 
75 (94%) 17 (89%) 
Antihypertensive 
monotherapy 
35 (44%) 7 (37%) 
Dual antihypertensive 
therapy 
24 (30%) 8 (42%) 
Triple antihypertensive 
therapy 
14 (17%) 1 (5%) 
ACEi‡/ARB§ 63 (79%) 14 (74%) 
Beta blocker 15 (19%) 6 (32%) 
Calcium channel blocker 33 (41%) 6 (32%) 
Thiazide diuretic 14 (18%) 3 (16%) 
 
*Transient ischaemic attack 
†Modified Rankin Score 
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‡Angiotensin-converting enzyme inhibitor 
§Angiotensin receptor blocker 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table II: Mean group systolic and diastolic blood pressure from each measurement 
method. Data presented are mean (SD). 
Measurement 
method 
Number of 
measurements 
Mean systolic 
BP* (mmHg) 
Mean diastolic 
BP* (mmHg) 
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Baseline CBPM† 3 (0) 150.8 (20.2) 85.1 (11.8) 
Baseline daytime 
ABPM‡ 
38.1 (9.1) 133.5 (13.7) 76.4 (8.5) 
Home BP* at six 
weeks 
27.3 (1.4) 140.1 (15.8) 78.5 (8.7) 
Home BP* at five 
months 
26.8 (3.1) 134.7 (13.7) 76.2 (9.7) 
Daytime ABPM‡ at 
six months 
37.2 (8.4) 127.6 (12.2) 74.2 (9.2) 
 
*Blood pressure 
†Clinic blood pressure measurement 
‡Ambulatory blood pressure monitoring 
 
 
 
 
 
 
 
 
 
 
 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
24 
 
 
 
 
 
 
Figure Legends 
Figure 1: Mean differences in blood pressure for head-to-head comparisons of out-
of-office measurement methods. Error bars are 95% confidence intervals. P values 
represent paired Student’s t-tests comparing the difference between measurement 
methods. ABPM denotes ambulatory blood pressure monitoring; HBPM, home blood 
pressure monitoring; SBP, systolic blood pressure; DBP, diastolic blood pressure. 
Figure 2: Bland-Altman plots to show the limits of agreement for within-individual 
blood pressure recorded by ambulatory monitoring (ABPM) and home monitoring 
(HBPM). Thick lines show the mean difference, dotted lines the 95% confidence 
interval for the mean difference, and dashed lines the limits of agreement (± 2 
standard deviations). A shows systolic blood pressure (SBP) comparing baseline 
ABPM and the first HBPM. B shows SBP comparing follow-up ABPM and the last 
HBPM. C shows diastolic blood pressure (DBP) comparing baseline ABPM and the 
first HBPM. D shows DBP comparing follow-up ABPM and the last HBPM. 
Figure 3: Histograms to show the change in the blood pressure difference recorded 
by ambulatory blood pressure monitoring and home blood pressure monitoring from 
the first to the second comparison for individuals. A shows the change in systolic 
blood pressure (SBP). B shows the change in diastolic blood pressure (DBP). 
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